I

Imara Inc.

15 employees

Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Genetics
Biopharma

Date founded

2016

Funding rounds raised

Total raised

$63M

from 8 investors over 8 rounds

I

Imara Inc. raised $63M on March 18, 2019

Investors: Lundbeckfonden / Lundbeck Foundation, OrbiMed Advisors, Bay City Capital, RA Capital Management, L.P. and Arix Bioscience plc

I

Imara Inc. raised $31M on April 14, 2016

Investors: Lundbeckfonden / Lundbeck Foundation and Bay City Capital

I

Imara Inc. raised $800K on January 1, 2016

Investors: Bay City Capital

FAQ